TOP STORIES

• BUSINESS Teva’s Global Medical Director Says Biosimilars Can Cut Medical Costs
  October 25, 2013

• REGULATORY Regulatory Reform Council to Convene Public Discussion on Expansion of “Mixed Healthcare” on November 28
  October 25, 2013

• REGULATORY Diovan Panel Should Question 4 Key Figures to Dig into Scandal Further: Expert Member
  October 24, 2013

• REGULATORY MOF Demands Hefty Price Cuts for Long-Listed Products, Skeptical about Premium
  October 23, 2013

• BUSINESS Swiss Novartis Sees 22% Plunge in January-September Diovan Sales
  October 23, 2013

• ORGANIZATION No Clear Violation of Fair Competition Code in Diovan Case: Maker FTC Exec
  October 22, 2013

• BUSINESS Wholesalers’ Sluggish Price Settlement Rate Could Mar Reliability of Market Price Survey
  October 22, 2013

• ORGANIZATION JPMA Will Announce Response to Violation of PAL by Mitsubishi Tanabe in Near Future: Director General Goto
  October 21, 2013

• REGULATORY Ex-Health Minister Nagatsuma Eyes Unsworn Diet Testimony by Ex-Novartis Employee on Diovan Scandal
  October 18, 2013

• REGULATORY CSIMC Pricing Subcommittee OKs Indicator to Gauge Reasonableness of Premium’s Perpetuation
  October 17, 2013

• BUSINESS Gilead to Fully Enter Japan, File for Approval for Hepatitis C Treatment Sofosbuvir in 2014: President
  October 16, 2013

• BUSINESS Once-Weekly DPP-4 Inhibitors of MSD, Takeda to Bring New Dimension to Packed Market
  October 15, 2013

• BUSINESS Gilead to Enter Japan Full Force with Hepatitis C Treatment
  October 11, 2013

• REGULATORY CSIMC Pricing Subcommittee to Explore “Responses” to Diovan Uproar
  October 10, 2013

• ORGANIZATION Japan Self-Medication Industry Requests Health Minister to Remove JMA, JPA Members from OTC Drug Review Council
  October 9, 2013

• ORGANIZATION Blanket 14-Day Prescription Limit Should Be Scrapped: EFPIA Japan Chair
  October 8, 2013

• BUSINESS Quintiles Aims to Expand Business in Japan with More Employees: CEO
  October 8, 2013

• BUSINESS 3 Combination Drugs for Asthma, COPD Get Approval to Fuel Competition; NHI Price Listing Expected in November
  October 7, 2013

• ORGANIZATION Diovan Issue　is “Isolated Example,” Confidence in Japan Clinical Trials Not Lost: President Viehbacher of EFPIA
  October 7, 2013

• REGULATORY NIBIO to Strengthen Academia’s Drug Discovery Support Initiatives in Order to Evaluate 400 Research Themes by FY2015
  October 4, 2013

ページ

• « 先頭
• ‹ Prev
• …
• 214
• 215
• 216
• 217
• 218
• 219
• 220
• 221
• 222
• …
• Next ›
• 最終 »